Longevity Clinics in North America

Across the United States, Canada and Mexico longevity clinics sell the same menu - whole-body magnetic resonance imaging (MRI), long blood panels, hormone prescribing and cell infusions - and in all three countries insurance and public cover pay for almost none of it. The gate is the same everywhere: an insured or public system buys a test when it is medically necessary, or when it sits on a short official prevention list, and whole-body scans and biological-age panels sit on neither. What changes at each border is not the test list but who may prescribe what afterwards.

The provider shapes differ accordingly. American listings are direct-pay practices, usually a membership or annual fee for access with imaging, laboratories and prescriptions billed on top; Canadian listings are mostly packaged executive health, sold lawfully in the uninsured space beside a single-payer system precisely because the day is not a medically required service; Mexican listings are largely inbound medical travel, quoted in US dollars for people who flew or drove in.

Inside each country the listings split again, between diagnostics-only operations that hand over a report and end the relationship, membership practices with a named responsible physician, and treatment-led clinics where the testing is the front end of an infusion and prescribing business.

Start with what the insured systems actually buy. In the United States the Affordable Care Act requires most health plans to cover, without cost sharing, preventive services graded A or B by the United States Preventive Services Task Force, immunisations recommended by the Advisory Committee on Immunization Practices, and the preventive care set out in Health Resources and Services Administration guidelines for women, infants, children and adolescents. That Task Force catalogue runs to a little over a hundred current topics and contains no recommendation for whole-body MRI, biological-age panels or advanced metabolomic testing, and Medicare separately excludes payment for routine physical checkups by statute.

Canada's Canada Health Act insures "hospital services, physician services and surgical-dental services", and defines physician services as "any medically required services rendered by medical practitioners", which leaves everything not medically required outside the plan and lawfully billable in private. British Columbia's Medical Services Plan states the boundary plainly, excluding preventive services and screening tests not supported by evidence of medical effectiveness and giving routine annual complete physical examinations, whole body computed tomography (CT) scans and prostate specific antigen (PSA) tests as its own examples. Ontario replaced the adult annual physical with a Periodic Health Visit after a November 2012 agreement between the province and the Ontario Medical Association, and every province sets its own approach.

Mexico's public cover is split between the social-security institutes for formal employees and Servicios de Salud del Instituto Mexicano del Seguro Social para el Bienestar (IMSS-Bienestar), the decentralised federal body created in 2022 to provide free medical and hospital care to people without social security. Neither is built around elective screening for people who are well.

Most of what these clinics offer has an ordinary route when there is a clinical reason for it. A symptom, an abnormal result or a documented family history gets the same MRI, the same cardiac imaging and the same hormone panel ordered inside the normal system in all three countries. What the private route sells is the same test without an indication, on a date of the buyer's choosing - which is also why the American College of Radiology, in a position statement adopted in 2000 and revised in 2002, said it did not believe there was sufficient evidence to justify recommending total body CT screening for patients with no symptoms or a family history suggesting disease.

Clinical responsibility sits with an individually licensed doctor, and each country has a register worth checking. American physicians are licensed state by state; Canadian physicians appear on the public register of a provincial college such as the College of Physicians and Surgeons of Ontario; Mexican practitioners hold a cédula profesional, the federal professional licence, searchable in the Registro Nacional de Profesionistas kept by the education ministry.

Mexican speciality certification runs through councils recognised by the Comité Normativo Nacional de Consejos de Especialidades Médicas, the national committee of speciality councils named in Article 81 of the general health law, and Mexico's Consejo de Salubridad General (General Health Council) separately certifies medical establishments on a voluntary basis, which is a checkable fact rather than a marketing badge.

Longevity medicine is not a certified speciality: the American Board of Medical Specialties has 24 member boards certifying physicians in 38 specialities and 89 subspecialities, and longevity is not among them. A fellowship or diploma in the field therefore comes from a private membership body and carries no licensing weight, because the licence is the state board, the provincial college register or the cédula.

Prescribing is where the three systems diverge most, and it is the practical reason people cross the southern border. Health Canada treats all cell therapies as drugs under the Food and Drugs Act, has authorised only three of them, and otherwise permits them solely inside a clinical trial it has approved. The United States Court of Appeals for the Ninth Circuit held in September 2024 that the stromal vascular fraction a clinic prepares from a patient's own fat is a drug under federal food and drug law, and is not exempt as a same-day surgical procedure.

Mexico requires a sanitary licence both for regenerative medicine establishments and for the handling of stem cells, and its federal health-risk regulator, the Comisión Federal para la Protección contra Riesgos Sanitarios (COFEPRIS), suspended a Mexico City clinic offering stem cell treatments in 2015 on the ground that such treatments lack authorisation because their efficacy is not proven. The southern difference is enforcement intensity and how a facility licence reads in marketing copy, not a legal green light.

On drugs, testosterone is a controlled substance on both sides of the northern border, listed in Schedule III of the American Controlled Substances Act and Schedule IV of Canada's Controlled Drugs and Substances Act, and distributing human growth hormone in the United States for any use other than a recognised medical condition authorised by the federal health secretary and ordered by a physician is a federal offence carrying up to five years in prison. An American compounding pharmacy may only work from a bulk substance that meets an applicable United States Pharmacopeia or National Formulary monograph, is a component of an approved drug, or appears on a list developed by the federal health secretary. Health Canada, separately, advised in April 2026 that peptides are generally regulated as prescription drugs in Canada and that unauthorised injectable peptides sold online, BPC-157 among them, are illegal and have not been assessed for safety, efficacy or quality.

The market has three shapes and they price differently. American listings sell access first and services second, so the headline membership figure and the first-year total are rarely the same number.

Canadian listings sell a packaged day that is lawfully private because it is not a medically required service. What British Columbia forbids is private payment and duplicate private insurance for the services its plan does insure, a prohibition the courts upheld and the Supreme Court of Canada left standing when it refused leave to appeal in April 2023. Mexican listings are quoted for arrivals, in US dollars, sometimes with the hotel and the airport transfer folded in.

Two quotes for what looks like the same package rarely describe the same work. The variables that move the number are whether a named physician reads the scan or a report is simply generated and posted, how much clinician time sits inside the fee against how much is billed afterwards, whether repeat testing at six or twelve months is included, whether the clinic owns the scanner or books slots on someone else's, and whether prescriptions, infusions and supplements are separate line items. Insurance is not the variable: in all three countries it pays for the incidental findings that follow, not for the screening that produced them.

Crossing a border adds questions no price list answers. Who explains an ambiguous nodule three weeks later, at home, on a Tuesday night; who holds the file - under Mexico's clinical records standard the record is the property of the institution or provider that generated it, the patient's entitlement is a clinical summary that has to be requested in writing, and the record is kept for a minimum of five years from the last medical act - and whether the follow-up scan requires another flight.

The United States Centers for Disease Control and Prevention tells medical travellers to make sure they can get any needed follow-up care at home, to carry copies of their medical records, and warns that follow-up for complications can be expensive and might not be covered by their insurance. The mundane version of that advice is to leave with the imaging on a disc and the raw laboratory values, not a summary letter.